Michael Ackermann, vice president of neurostimulation at the pharmaceutical giant Allergan, offers thoughts on how healthcare policy will be affected by the election of Donald Trump as America’s commander in chief. On the day after Trump was elected president, Ackermann discussed how much is unknown about the new administration and its agenda, how another system for encouraging Americans to get insured may replace the Affordable Care Act if it is dismantled, and how soaring healthcare costs will remain a major issue.

Video clips from: A Tearful Tale of Biodesign [Entire Talk]

2 minutes

Healthcare Uncertainties Under Trump

Watch now

3 minutes

Entry Barriers as Buffers

Watch now

3 minutes

Acquisition Can Amplify Impact

Watch now

5 minutes

Why Tech Hasn’t Transformed Healthcare

Watch now

5 minutes

Trends and Opportunities in Healthcare

Watch now

Share Post